New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection

FRONTIERS IN PHARMACOLOGY

FRONTIERS MEDIA SA

1. National Natural Science Foundation of China [31701114, 21672266]
2. Guangdong Basic and Applied Basic Research Foundation [2019A050510019]
3. Science and Technology Planning Project of Guangdong Province [2017B030314030]
4. Guangzhou Science and Technology Planning Program [202002020051]
5. National Engineering Research Center for New Drug and Druggability Evaluation, Seed Program of Guangdong Province [2017B090903004]